首页> 外文期刊>Pathobiology: journal of immunopathology, molecular and cellular biology >Infrastructure and Facilities for Human Biobanking in Low- and Middle-Income Countries: A Situation Analysis
【24h】

Infrastructure and Facilities for Human Biobanking in Low- and Middle-Income Countries: A Situation Analysis

机译:中低收入国家的人类生物银行基础设施和设施:现状分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To collect information on biobanking facilities in low-and middle-income countries (LMICs) as a first step towards establishing an LMIC biobank and cohort building network (BCNet) to support research, with a focus on cancer control. Method: Sixty centres were identified from sources including cancer centres, universities, hospitals, and public health facilities and invited to participate in a survey between December 2012 and March 2013. Results: Of the 27 centres (45%) that responded, most have existed for < 10 years. They store between 1,000 and 1,000,000 research samples as well as samples remaining after clinical diagnosis. Sample storage is mostly in freezers, although 45% (9/20) of the centres do not have regular access to electricity. Biobank managers, sample management systems, and mechanisms for follow-up using linkages are uncommon. Many (80%; 21/26) of the centres have regulations to govern research, but regulations for the use of biobank resources (samples and data) are not well developed. Conclusions: Biobanking facilities are being developed in LMICs. Shortcomings in international visibility, sample sharing regulations, standardization, quality assurance, and sample management systems could be alleviated by international networking. Stakeholders need to work together to increase access to high-quality biological resources for scientific research. (C) 2015 S. Karger AG, Basel
机译:目的:收集有关中低收入国家(LMIC)生物银行设施的信息,这是建立LMIC生物银行和队列建设网络(BCNet)以支持研究的第一步,重点是癌症控制。方法:从包括癌症中心,大学,医院和公共卫生设施在内的来源中识别出60个中心,并邀请他们参加2012年12月至2013年3月之间的调查。结果:在做出答复的27个中心(占45%)中,大多数已经存在<10年。他们存储了1,000至1,000,000个研究样本以及临床诊断后剩余的样本。尽管45%(9/20)的中心没有定期通电,但样品存储大多在冰柜中。生物库管理人员,样品管理系统以及使用链接进行跟进的机制并不常见。许多中心(80%; 21/26)都有管理研究的法规,但是关于生物库资源(样本和数据)使用的法规尚不完善。结论:中低收入国家正在开发生物银行设施。国际网络可以缓解国际知名度,样品共享法规,标准化,质量保证和样品管理系统方面的缺陷。利益相关者需要共同努力,以增加获得用于科研的高质量生物资源的机会。 (C)2015 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号